Actively Recruiting

Age: 18Years +
All Genders
NCT06959173

Organoid-guided Personalized Treatment of Pleural Effusion

Led by Henan Cancer Hospital · Updated on 2025-05-06

20

Participants Needed

1

Research Sites

97 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is a single-arm, single-center clinical research that utilizes patient-derived tumor organoids to predict drug sensitivity, thereby assisting clinicians in formulating treatment plans to benefit lung cancer patients with pleural effusion. This study is divided into three parts: acquisition of clinical samples from patients, in vitro organoid culture and drug sensitivity testing, and correlation of organoid sensitivity results with clinical medication guidance. Researchers obtained pre-treatment tissue samples and provided them to Suzhou Xianjue Biotechnology Co., Ltd. to establish organoid models. Once established, drug incubation was performed for sensitivity testing. Subsequently, treatment for malignant pleural effusion was guided based on drug sensitivity data.

CONDITIONS

Official Title

Organoid-guided Personalized Treatment of Pleural Effusion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Able to understand and voluntarily sign informed consent
  • Good compliance and ability to cooperate with diagnosis and follow-up
  • ECOG performance status score of 0 to 2
  • Presence of malignant pleural effusion
  • At least one measurable lesion as assessed by the investigator
Not Eligible

You will not qualify if you...

  • History of malignant tumor within the past 5 years
  • Serious complications such as uncontrolled heart disease, severe arrhythmia needing treatment, or persistent watery diarrhea
  • Pregnant or lactating female patients
  • Patients considered unsuitable for participation by the study team

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Henan cancer hospital

Zhengzhou, Henan, China, 475000

Actively Recruiting

Loading map...

Research Team

Q

Qiming Wang

CONTACT

S

Sen Yang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here